OSSIO
Ronit Merchav-Feuermann has an extensive background in veterinary medicine and surgery, with experience working in both clinical and medical affairs. They have held positions as a veterinary surgeon and principal veterinary surgeon in various locations including Israel and the USA. Ronit currently serves as the VP of Clinical & Medical Affairs at OSSIO, Ltd. and also holds the title of Medical Director and Preclinical Manager. Their educational background includes a DVM degree, a rotating internship program, and a residency program in general and orthopedic surgery.
This person is not in any offices
OSSIO
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.